United States

Primary Hepatocytes Market to Surpass US$ 486 Million, Expanding at 6.6% CAGR by 2034 | Fact.MR Analysis

Global Primary Hepatocytes Market Value to Rise Through 2034 with Advancement of Liver Cell-based Assays

Rockville, MD, Feb. 05, 2025 (GLOBE NEWSWIRE) — In 2019, the net worth of the global 

Primary Hepatocytes Industry News:

  • In May 2022, the US-based BioIVT Company announced that its recently launched line of human primary hepatic cells now includes high-purity Kupffer cells. The company goes on to say that these new cells are meant to help with the development of various liver disease treatments and medications.
  • HemaCare Corp., one of the leading providers of primary hepatocytes for use in clinical and research settings, was acquired by the US-based Charles River Laboratories in January 2022. Following this acquisition, Charles River intends to expand its scientific capabilities in the area of high-growth cell therapy.

Check out More Related Studies Published by Fact.MR:

The global liver cancer diagnostics market reached a valuation of around US$ 11.73 Bn in 2022 and is slated to accelerate at a CAGR of 8.2% to top US$ 26 Bn by 2032.

The global in vitro diagnostics test kits market is estimated to stand at US$ 12.35 billion in 2024 and is evaluated to increase at a CAGR of 6.4% to reach US$ 22.93 billion by 2034.

The global lab automation market size is anticipated to grow significantly, with a compound annual growth rate (CAGR) of 7% from 2022 to 2032, and is projected to reach from US$ 1.8 billion in 2021 to US$ 4 billion in 2032.

The global triple combination therapy market was valued at US$ 15.5 billion in 2024 and has been forecasted to expand at a noteworthy CAGR of 6.5% to end up at US$ 29.2 billion by 2034.

The brain tissue oxygen monitoring system market is currently valued at US$ 4 billion in 2024. Furthermore, the market is evaluated to expand at a CAGR of 10.3% reaching the valuation of US$ 10.62 billion by the end of 2034.

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team[email protected]
Follow Us: LinkedIn | Twitter | Blog

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker